News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
188 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26128)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (179)
2 (151)
3 (82)
4 (11)
5 (19)
6 (2)
7 (1)
8 (200)
9 (246)
10 (182)
11 (223)
12 (56)
13 (2)
14 (10)
15 (152)
16 (255)
17 (188)
18 (170)
19 (74)
20 (3)
21 (9)
22 (155)
23 (232)
24 (190)
25 (213)
26 (67)
27 (4)
28 (5)
29 (170)
30 (200)
31 (192)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Deals
Bruker Comments on Block Trade Transaction - July 17, 2019
Bruker Corporation has been advised that former board member, Mr. Joerg C. Laukien, has authorized a block sale of Bruker shares as part of his retirement planning and portfolio diversification.
July 17, 2019
·
1 min read
Deals
The Medicines Company to Announce Second Quarter 2019 Financial Results on July 24
The Medicines Company will host a conference call and audio webcast on Wednesday, July 24, 2019 at 8:30 a.m. EDT to discuss its second quarter 2019 financial results and operational developments.
July 17, 2019
·
1 min read
Business
Ontera Welcomes Dr. J. Wallace Parce to Its Advisory Board
Ontera, the leader in silicon-based nanopore diagnostics, today announced the appointment of Dr. J. Wallace (Wally) Parce to its Advisory Board. Dr. Parce comes to Ontera as a respected and successful serial entrepreneur in life science technology development and commercialization
July 17, 2019
·
2 min read
Business
Escient Pharmaceuticals Appoints Kristin Taylor, PhD as Vice President and Head of Clinical Development
Seasoned industry leader to steer Escient’s clinical development and regulatory strategies as it advances first-in-class Mrgpr-focused pipeline
July 17, 2019
·
3 min read
Business
Abbott Reports Second-Quarter 2019 Results
Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2019.
July 17, 2019
·
32 min read
Kazia calls for greater awareness of the deadliest brain cancer in the US
This Glioblastoma Awareness Day, Australian oncology-focused biotech company, Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA), calls for greater awareness of the most lethal brain cancer in the US.
July 17, 2019
·
1 min read
Business
Revance Adds Life Sciences Audit Executive Chris Nolet to Board of Directors
Nolet will serve as Chair of the Audit Committee
July 17, 2019
·
5 min read
Pharm Country
Menarini Silicon Biosystems Launches VRNxT Volume Reduction Instrument
Automated volume reduction increases precision and accuracy in rare cell workflows
July 17, 2019
·
3 min read
Business
Neurotrope Strategic Advisory Board Members Participating in Key Opinion Leader Call Sponsored by Oppenheimer’s Biotechnology Team
Neurotrope Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer’s disease (AD), today announced that two of the Company’s Scientific Advisory Board members will be participating in a key opinion leader (KOL) call being sponsored by Oppenheimer & Co. Inc.'s Biotechnology team.
July 17, 2019
·
3 min read
Business
Gilead Sciences’ Chief Scientific Officer John McHutchison to Leave the Company
The company will immediately commence a search for his successor.
July 17, 2019
·
2 min read
Previous
6 of 19
Next